【ORGABIO 0252 交流专区】

Tony-Pua

（吉隆坡13日讯）速溶咖啡代工商——康泰控股（ORGABIO HOLDINGS BERHAD），计划上市大马交易所创业板，首次公开售股（IPO）将发行近9667万新股，发售价待定。

据康泰控股呈交予证监会的草拟招股书，上述9667万股中，约1239万股将开放给公众认购，普通和土著投资者参半；近620万股会提供给符合资格的董事、职员和有功于公司者。

另外，近7808万新股将以私下配售形式，发放予特定投资者。上市成功后，该公司总股数将扩大至接近2亿4787万股。

透过IPO筹集的金额，将用来建造新厂、偿还银行贷款、购买设备、作为营运资本等等。

该公司也指出，新厂将坐落在雪州士毛月，预计在2023年3月完工。

据康泰控股的官方网站，旗下产品包括咖啡豆、三合一速溶咖啡、保健食饮品等等。

招股书显示，康泰控股在2020财政年取得营收3937万令吉，净利为564万令吉。

其中3255万令吉或83%营收来自大马市场；另682万令吉或17%来自海外市场。

新加坡和中国是该公司的主要国外市场，个别贡献营收233万和163万令吉，占总营收的6%及4%。

另一方面，该公司现阶段并没有制定股息政策，未来派息与否，取决于独资子公司贡献多少盈利。

Tony-Pua

（吉隆坡30日讯）预计将在12月前上市马股创业板的速溶饮料制造商康泰食品（Orgabio Holdings Berhad），与合盈证券签署首次公开募股（IPO）包销协议。

根据周四的文告，康泰食品此次IPO将公开发售9670万股新股，相当于扩大后股本的39%。

合盈证券将负责分销该公司的1860万股新股，供大马公众、符合资格董事、员工和有贡献人士认购；剩余的7810万股新股，将私配给特定投资者和获国际贸工部批准的土著投资者。

另外，这项IPO已获海鸥（HAIO，7668，主板消费股）支持，成为基石投资者。

康泰食品执行副主席拿督欧阳丁清表示，对于海鸥能够成为公司的基石投资者，感到万分欣喜。

“海鸥的投资承诺，展现了该集团对公司、商业模式、经营策略和经营团队的信任。”

此次IPO所筹集的资金，主要用于支付该公司士毛月新厂房的融资和银行贷款，而部分资金将用于采购支援和提高效率的新机器、营运资本以及上市活动资金。

欧阳丁清点出，建造新厂房，除了能量身定制产品种类外，还能优化现有机器的配置，以提高制造程序的流线和连贯性。

康泰食品的核心业务，是为第三方品牌公司提供速溶饮料制造服务；该公司也经营自家品牌Everyday和BrogaHill速溶饮料的制造、销售和行销等。

另外，合盈证券是这次上市活动的顾问、赞助商、包销商，及配售商。

出席今日签约活动的，还有康泰食品执行董事欧阳捍仁、总执行长兼执行董事欧阳捍文、合盈证券企业融资董事经理拿督陈俊㟽、董事拿督黄景基，及及企业融资主管丁华代。

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2022

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2022	31 Mar 2021	31 Mar 2022	31 Mar 2021
		$$'000	$$'000	$$'000	$$'000

1	Revenue	13,484	0	48,327	0
2	Profit/(loss) before tax	1,832	0	5,653	0
3	Profit/(loss) for the period	1,379	0	4,085	0
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,379	0	4,085	0
5	Basic earnings/(loss) per share (Subunit)	0.91	0.00	3.43	0.00
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1500		22.2500

icy97

ORGABIO HOLDINGS BERHAD

SUMMARY OF KEY FINANCIAL INFORMATION 31 Dec 2023

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Dec 2023	31 Dec 2022	31 Dec 2023	31 Dec 2022
		$$'000	$$'000	$$'000	$$'000

1	Revenue	18,656	18,817	30,805	33,291
2	Profit/(loss) before tax	1,730	245	1,861	136
3	Profit/(loss) for the period	971	11	1,016	-766
4	Profit/(loss) attributable to ordinary equity holders of the parent	971	11	1,016	-766
5	Basic earnings/(loss) per share (Subunit)	0.39	0.01	0.41	-0.31
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2100		0.2100

Date of change	01 Mar 2024
Name	DR TEH CHEE GHEE
Age	57
Gender	Male
Nationality	Malaysia
Type of change	Redesignation
Previous Position	Non Executive Chairman
New Position	Non Executive Director
Directorate	Independent and Non Executive

Date of change	01 Mar 2024
Name	MR EAN YONG HIAN WAH
Age	44
Gender	Male
Nationality	Malaysia
Designation	Executive Chairman
Directorate	Executive
Type of change	Appointment

Qualifications

No	Qualifications	Major/Field of Study	Institute/University	Additional Information
1	Diploma	Commerce & Administration	New Era College
2	Degree	Bachelor of Arts (Hons) in Business Studies	University of Bradford, United Kingdom
3	Others	Certificate in Accounting & Finance for Non-financial Managers, Executive Education Programme	NUS Business School, Singapore

Working experience and occupation	Mr Ean Yong Hian Wah ("Mr Hian Wah") began his career in 2004 when he was appointed as Marketing Director of Orgapharma Herbal Manufacturing Sdn. Bhd. ("OHMSB") where he is responsible for the development of marketing initiatives for OHMSB, overseeing branding strategies and promoting the Company's products in the market. In 2008, Mr Hian Wah served as a dedicated State Assemblyman for Seri Kembangan for a remarkable tenure of 15 years. Throughout his tenure, he exhibited an unwavering commitment to the welfare and interests of his constituents, tirelessly advocating for their needs, championing legislative reforms, and actively contributing to the formulation of policies aimed at fostering socio-economic development and community empowerment within the region.Mr Hian Wah commitment to public service extended further as he assumed the role of State Executive Councilor (EXCO) of the Selangor State Government from 2008 to 2018. He also served as a Director of Invest Selangor Berhad from 2013 to 2015, where he played a pivotal role in attracting investment, fostering business growth, and promoting Selangor as a premier investment destination. In 2023, Mr Hian Wah was appointed as the Chairman of the Port Klang Authority, overseeing strategic initiatives and operations to optimise port efficiency and drive economic growth in the region. Currently, he also a General Manager of Everyday F&B Manufacturing Sdn. Bhd., an wholly-owned subsidiary of the Company.
Directorships in public companies and listed issuers (if any)	Nil
Family relationship with any director and/or major shareholder of the listed issuer	Mr Ean Yong Hian Wah is the son of Dato Ean Yong (Executive Deputy Chairman of Orgabio) and Datin Lai You Mooi, and the sibling of Ean Yong Hien Voon (Executive Director / Chief Executive Officer of Orgabio), Ean Yong Hen Loen (Executive Director of Orgabio), Ean Yong Hien Chal, Ean Yong Han Khian and Ean Yong Sik Siew (Chief Operating Officer of Orgabio), all of which are the major shareholders of the Company.
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	Direct Interest - Nil Indirect Interest - 154,286,798 shares

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2024

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2024	30 Jun 2023	30 Jun 2024	30 Jun 2023
		$$'000	$$'000	$$'000	$$'000

1	Revenue	20,904	13,224	74,139	58,835
2	Profit/(loss) before tax	1,421	667	5,647	151
3	Profit/(loss) for the period	974	630	4,109	-882
4	Profit/(loss) attributable to ordinary equity holders of the parent	974	630	4,109	-882
5	Basic earnings/(loss) per share (Subunit)	0.39	0.25	1.66	-0.36
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2200		0.2100

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) COMBINATION OF NEW ISSUE OF SECURITIES
Description	ORGABIO HOLDINGS BERHAD ("ORGABIO" OR THE "COMPANY")(I)        PROPOSED BONUS ISSUE OF UP TO 61,967,000 FREE WARRANTS IN ORGABIO ("WARRANT(S)") ON THE BASIS OF 1 WARRANT FOR EVERY 4 EXISTING ORDINARY SHARES IN ORGABIO HELD ON AN ENTITLEMENT DATE TO BE DETERMINED AND ANNOUNCED LATER; AND(II)        PROPOSED ESTABLISHMENT OF AN EMPLOYEES' SHARE SCHEME OF UP TO 10% OF THE TOTAL NUMBER OF ISSUED SHARES (EXCLUDING TREASURY SHARES, IF ANY) OF ORGABIO (COLLECTIVELY REFERRED TO AS THE "PROPOSALS")
On behalf of the Board of Directors of Orgabio, RHB Investment Bank Berhad wishes to announce that the Company proposes to undertake the following: (i) bonus issue of up to 61,967,000 free Warrants on the basis of 1 Warrant for every 4 existing ordinary shares in Orgabio held on the entitlement date to be determine and announced later; and (ii) establishment of an employees' share scheme ("ESS") of up to 10% of the total number of issued shares (excluding treasury shares, if any) of the Company at any point in time during the duration of the ESS. Further details of the Proposals are set out in the attachment below. This announcement is dated 2 October 2024.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3488519

Attachments Orgabio Holdings Berhad_Initial Announcement (2 October 2024).pdf